Please log in to determine if you are eligible to purchase PT Programs.
RNA FUSIONS, HEMATOLOGIC MALIGNANCIES - RNAH
RNAH
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte/Procedure Challenges per Shipment Number of Shipments
RNA fusions, hematologic malignancies 3 Two shipments per year


Additional Information

  • This program is for laboratories using RNAseq to detect gene fusion transcripts.
  • Total RNA from GM24385 cell line containing biosynthetic fusion RNA
  • Potential fusion variants include BCR::ABL1, ETV6::RUNX1, and KMT2A::MLLT3.

  • Program Information

    • Three 500-ng RNA (20 ng/μL) specimens

    Shipping Schedule

    • Shipment A: May 25
    • Shipment B: November 2






Customers Who Bought This Item Also Bought
MHO, LYMPHOMA
VIEW DETAILS >
MHO1, LYMPHOMA, DOUBLE VOLUME
VIEW DETAILS >
MHO2, LEUKEMIA ONLY
VIEW DETAILS >
MHO3, LEUKEMIA ONLY, DOUBLE VOLUME
VIEW DETAILS >
DNA EXTRACTION & AMPLIFICATION FFPE
VIEW DETAILS >
RNA FUSIONS, SOLID TUMOR
VIEW DETAILS >